Primary care prescribing data for drugs to treat obesity

In the UK, it is estimated that 1 in 4 adults are obese. For patients who meet certain criteria, adjunctive therapies are available on prescription, these include lipase inhibitors and glucagon-like-peptides (GLP-1). All prescribing data for these therapies is collated in GPrX Data’s quality assured dataset and is available via any of our solutions: Online, Enterprise or as a custom query. For more information about our offerings please see our Solutions pages.

For a prescribing data snapshot for the obesity sector, please see the RxIndex below.


GPrX Data Ltd

More on obesity from GPrX

Sector specific resources for the obesity market coming soon!

Ready to start the conversation?

Our friendly team loves talking data. Schedule a chat or an online demo now!